drugset / Trial / NCT03428464
Bicarbonate Administration in Kidney Transplant Recipients
RandomizedCrossoverQuadruple-blindTreatment
Summary
Metabolic acidosis is associated with vascular endothelial dysfunction and is a common complication in patients who have received a kidney transplant. Kidney transplant recipients (KTR) with lower serum bicarbonate levels, even within the normal range, have an increased risk of graft loss and mortality. The investigators propose a prospective, double-blind, randomized, placebo-controlled, 18-week crossover pilot study to examine the effects of sodium bicarbonate on vascular endothelial function, graft function, and cognitive function in 20 KTR patients.
Timeline
- Start
- 2018-12-05
- Primary completion
- 2020-03-25
- Completion
- 2020-03-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 0.5 meq | Oral |